A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine

AAPS Journal

Volumn 7, Issue 3, 2005, Pages

  Ayers, Joshua T ^a,b   Xu, Rui ^a,c   Dwoskin, Linda P ^a   Crooks, Peter A ^a  

^a University of Kentucky   (United States)

^b ASTRAZENECA   (United Kingdom)

^c ARRAY BIOPHARMA INC   (United States)

Author keywords

Nicotiana alkaloids; Stereoselective synthesis; Tobacco

Indexed keywords

ALKALOID; ALKANE DERIVATIVE; AMINE; ANABASINE; ANATABINE; HALOGEN; HYDROXYL GROUP; METHYL GROUP; NORNICOTINE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; NICOTINE;

ALKYLATION; ARTICLE; CATALYSIS; CHEMICAL REACTION; CHIRALITY; CONTROLLED STUDY; DEPROTECTION REACTION; DRUG PURITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; ENANTIOSELECTIVITY; ISOMER; NONHUMAN; POLYMERIZATION; TOBACCO; STEREOISOMERISM; SYNTHESIS;

ALKALOIDS; ANABASINE; NICOTINE; PYRIDINES; STEREOISOMERISM; TOBACCO;

EID: 33646658696     PISSN: 15221059     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/aapsj070375     Document Type: Article

References (35)

1. Bush LH, Hempfling WP, Burton H. Chemical properties of nicotine and other tobacco-related compounds. In: Gorrod JW, Jacob P, III, eds. Analytical Determination of Nicotine and Related Compounds and Their Metabolites. New York, NY: Elsevier; 1999:69-147.
2. Armstrong DW, Wang X, Lee JT, Liu YS. Enantiomeric composition of nornicotine, anatabine, and anabasine in tobacco. Chirality. 1999;11:82-84,
3. Crooks PA, Godin CS, Pool WF. Enantiomeric purity of nicotine in tobacco smoke. Med Sci Res, 1992;20:879-880.
4. Crooks PA, Dwoskin LP. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem Pharmacol. 1997;54:743-753.
5. Copeland JR, Adem A, Jacob P III, Nordberg A. A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol. 1991;343:123-127,
6. Reavill C, Jenner P, Kumar R, Stolerman IP. High affinity binding of [3H](-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology. 1988;27:235-241.
7. Xu R, Dwoskin LP, Grinevich VP, Deaciuc G, Crooks PA. Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues. Bioorg Med Chem Lett. 2001;11:1245-1248.
8. Bardo MT, Bevins RA, Klebaur JE, Crooks PA, Dwoskin LP. Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats. Pharmacol Biochem Behav. 1997;58:1083-1087.
9. Green TA, Phillips SB, Crooks PA, Dwoskin LP, Bardo MT. Nornicotine pretreatment decreases intravenous nicotine self-administration in rats. Psychopharmacology (Berl). 2000;152:289-294.
10. Green TA, Crooks PA, Bardo MT, Dwoskin LP. Contributory role for nornicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices. Biochem Pharmacol. 2001;62:1597-1603.
11. Dwoskin LP, Buxton ST, Jewell AL, Crooks PA. (-)-Nornicotine increases dopamine release in a calcium-dependent manner from superfused rat striatal slices. J Neurochem. 1993;60:2167-2174.
12. Teng L, Crooks PA, Buxton ST, Dwoskin LP. Nicotinic-receptor mediation of S(-)nornicotine-evoked 3H-overflow from rat striatal slices preloaded with -3H-dopamine. J Pharmacol Exp Ther. 1997;283:778-787.
13. Kyerematen GA, Morgan M, Chattopadhyay B, deBethizy JD, Vesell ES. Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinine. Clin Pharmacol Ther. 1990;48:641-651.
14. Crooks PA, Li M, Dwoskin LP. Metabolites of nicotine in rat brain after peripheral nicotine administration: cotinine, nornicotine, and norcotinine, Drug Metab Dispos. 1997;25:47-54.
15. Ghosheh O, Dwoskin LP, Li WK, Crooks PA. Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2′-14C]nicotine. Drug Metab Dispos. 1999;27:1448-1455.
16. Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A. Long-lasting occupancy of central nicotine acetylcholine receptors after smoking: a PET study in monkeys. J Neurochem. 2003;84:105-111.
17. Ghosheh O, Dwoskin LP, Miller DK, Crooks PA. Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2′-14C]-nicotine. Drug Metab Dispos. 2001;29:645-651.
18. Risner ME, Cone EJ, Benowitz NL.. Jacob P III. Effects of stereoisomers of nicotine and nornicotine on schedule controlled responding by beagle dogs and squirrel monkeys. J Pharmacol Exp Ther. 1988;244:807-813.
19. Bardo MT. Green TA, Crooks PA, Dwoskin LP. Nornicotine is self-administered intravenously by rats. Psychopharmacology (Berl). 1999; 146:290-296,
20. Corrigall WA, Coen KM. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl). 1989;99:473-478.
21. Middleton LS, Crooks PA, Wedlund PJ, Cass WA, Dwoskin LP. Nornicotine inhibition of striatal dopamine transporter function via nicotinic receptor activation. J Pharmacol Exp Ther. 2005;
22. Crooks P, Dwoskin L, Bardo M, inventor. Nornicotine enantiomers for use as a treatment for dopamine-related conditions and disease states. US patent 5776957. July 8, 1998.
23. Dwoskin LP, Teng L, Buxton ST, Ravard A, Deo N, Crooks PA. Minor tobacco alkaloids release [3H] dopamine from superfused rat striatal slices. Eur J Pharmacol. 1995;276:195-199.
24. Grady S, Marks MJ, Wonnacott S, Collins AC. Characterization of nicotinic receptor-mediated [3H] dopamine release from synaptosomes prepared from mouse striatum. J Neurochem. 1992;59:848-856.
25. Crooks PA. Chemical properties of nicotine and other tobacco-related compounds. In: Gorrod JW, Jacob P, eds. Analytical Determination of Nicotine and Related Compounds and Their Metabolites. New York, NY: Elsevier; 1999:69-147.
26. Deo NM, Crooks PA. Regioselective alkylation of N-(diphenylmethylidine)-3-(aminomethyl)pyridine: a simple route to minor tobacco alkaloids and related compounds. Tetrahedron Lett. 1996;37:1137-1140.
27. Yus M, Soler T, Foubelo F. A new and direct synthesis of 2-substituted pyrrolidines. J Org Chem. 2001;66:6207-6208.
28. Loh T, Zhou J, Li X, Sim K. A novel reductive aminocyclization for the syntheses of chiral pyrrolidines: stereoselective syntheses of (S)-nornicotine adn 2-(2′-pyrrolidyl)-pyridines. Tetrahedron Lett. 1999;40:7847-7850.
29. Felpin FX, Girard S, Vo-Thanh G, Robins RJ, Villieras J, Lebreton J. Efficient enantiomeric synthesis of pyrrolidine and piperidine alkaloids from tobacco. J Org Chem. 2001;66:6305-6312.
30. Amat M, Canto M, Llor N, Bosch J. Enantioselective synthesis of 2-arylpiperidines from chiral lactams. A concise synthesis of (-)-anabasine. Chem Comm. 2002;5:526-527.
31. Balasubramanian T, Hassner A. Asymmetric synthesis of functionalized piperidine derivatives: synthesis of (S)-anatabine. Tetrahedron Asymmetry. 1998;9:2201-2205.
32. Aiqiao M, Xun X, Lanjun W, Yaozhong J. Asymmetric synthesis XV: enantioselective sytheses of (R) or (S)-alpha-substituted -(2-pyridyl) methylamines via chiral pinanone ketimine template. Synth Comm. 1991;21:2207-2212.
33. Swango JH, Bhatti BS, Qureshi MM, Crooks PA. A novel enantioselective synthesis of (S)-(-)- and (R)-(+)-nornicotine via alkylation of a chiral 2-hydroxy-3-pinanone ketimine template. Chirality, 1999;11:316-318.
34. Ayers JT, Sonar VN, Parkin S, Dwoskin LP, Crooks PA. (1R,2R.5R)-(+)-2alfa-hydroxypinan-3-one ketamine. Acta Cryst Sect E. 2005;E61:02682-02684.
35. Mehmandoust M, Marazano C, Das BC. A stereoselective route to enantiomeric 2-alkyl-1,2,3,6-tetrahydropyridines. J Chem Soc Chem Commun. 1989;1185-1144.